AcelRx Pharmaceuticals to Present at the Piper Jaffray 24th Annual Healthcare Conference
REDWOOD CITY, Calif., Nov. 20, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and CEO, will present a corporate overview at the Piper Jaffray 24th Annual Healthcare Conference at The New York Palace in New York, NY. The presentation is scheduled for Tuesday, November 27, 2012 at 11:00 a.m. ET/8:00 a.m. PT.
SOURCE AcelRx Pharmaceuticals, Inc.
More by this Source
Zalviso™ New Drug Application Accepted for Filing by FDA
Dec 02, 2013, 07:30 ET
AcelRx Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
Nov 26, 2013, 07:30 ET
AcelRx Pharmaceuticals Reports Third Quarter 2013 Financial Results
Nov 05, 2013, 16:05 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.